FUNCTIONALLY CHARACTERIZING THE NONCODING GENOME OF METASTATIC PROSTATE CANCER TO IDENTIFY THERAPEUTIC VULNERABILITIES.

$945,271FY2021Department of the ArmyDOD

Dana-Farber Cancer Institute, Inc.

Investigators